Crispr: Upcoming Catalysts, Plenty Of Cash And Strong Partnerships Make It A Buy
Seeking Alpha,
Summary CRISPR Therapeutics has upcoming catalysts and a strong cash position, making it a solid investment opportunity.
Summary CRISPR Therapeutics has upcoming catalysts and a strong cash position, making it a solid investment opportunity.
A research paper published a decade ago touched off a biomedical revolution that has made careers, spawned companies and drawn…
A research paper published a decade ago touched off a biomedical revolution that has made careers, spawned companies and drawn…
Sanofi is upping its investment in gene editing, expanding an existing collaboration with California-based Scribe Therapeutics…